Form 4: Chemours CFO Shane Hostetter Reports Acquisition of Shares and Stock Options

Chief Financial Officer of Chemours, Shane Hostetter, reports acquiring shares and stock options in the company.

Summary

• On March 3, 2025, Shane Hostetter, the Chief Financial Officer of Chemours Co, acquired 27,326 shares of common stock at $0.00 and was granted stock options to purchase 90,827 shares at an exercise price of $13.86 and 94,460 shares at an exercise price of $15.25.
• Following these transactions, Hostetter directly owns 54,035 shares of Chemours Co.
• The stock options vest in three equal annual installments beginning on March 3, 2026, and expire on March 3, 2035.
• The restricted stock units are scheduled to vest in three equal annual installments beginning on March 1, 2026.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and stock options by the CFO indicates confidence, but it's a routine transaction.

Positives

• The acquisition of shares and stock options by a high-ranking executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedules for the restricted stock units and stock options suggest a long-term commitment by the executive to the company's success.

Industry Context

Executive compensation through stock options and restricted stock units is a common practice in publicly traded companies to align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in the chemicals industry, similar to companies like Dow and DuPont.
• The vesting schedules are also standard, often spanning three to four years to incentivize long-term performance.

Stakeholder Impact

• The acquisition of shares by a key executive could positively influence investor sentiment.

Key Dates